On the public citation graph
Activating mutations in ALK provide a therapeutic target in neuroblastoma
0 signed · 876 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/med.20109openalex-snapshot
Development of anaplastic lymphoma kinase (ALK) small‐molecule inhibitors for cancer therapy
inferredcites →https://doi.org/10.1016/j.ccr.2007.11.005openalex-snapshot
Identification of Driver and Passenger Mutations of FLT3 by High-Throughput DNA Sequence Analysis and Functional Assessment of Candidate Alleles
inferredcites →https://doi.org/10.1016/j.cell.2007.11.025openalex-snapshot
Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer
inferredcites →https://doi.org/10.1016/s0002-9440(10)62966-5openalex-snapshot
Biological Role of Anaplastic Lymphoma Kinase in Neuroblastoma
inferredcites →https://doi.org/10.1016/s0002-9440(10)65042-0openalex-snapshot
Expression of the ALK Tyrosine Kinase Gene in Neuroblastoma
inferredcites →https://doi.org/10.1038/431525bopenalex-snapshot
Intragenic ERBB2 kinase mutations in tumours
inferredcites →https://doi.org/10.1038/nature05945openalex-snapshot
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
inferredcites →https://doi.org/10.1038/nrc2291openalex-snapshot
The anaplastic lymphoma kinase in the pathogenesis of cancer
inferredcites →https://doi.org/10.1038/sj.onc.1205735openalex-snapshot
Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines
inferredcites →https://doi.org/10.1038/sj.onc.1209348openalex-snapshot
Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecan
inferredcites →https://doi.org/10.1056/nejm199910143411601openalex-snapshot
Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
inferredcites →https://doi.org/10.1056/nejmoa040938openalex-snapshot
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
inferredcites →https://doi.org/10.1073/pnas.0609412103openalex-snapshot
Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK
inferredcites →https://doi.org/10.1093/nar/25.14.2745openalex-snapshot
PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing
inferredcites →https://doi.org/10.1126/science.1099314openalex-snapshot
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
inferredcites →https://doi.org/10.1126/science.1141478openalex-snapshot
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
inferredcites →https://doi.org/10.1126/science.1142946openalex-snapshot
Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies
inferredcites →https://doi.org/10.1126/science.8122112openalex-snapshot
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
inferredcites →https://doi.org/10.1158/0008-5472.can-05-1829openalex-snapshot
Epidermal Growth Factor–Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle Progression
inferredcites →https://doi.org/10.1158/0008-5472.can-07-6186openalex-snapshot
Genomic Alterations of Anaplastic Lymphoma Kinase May Sensitize Tumors to Anaplastic Lymphoma Kinase Inhibitors
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-0168openalex-snapshot
EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
inferredcites →https://doi.org/10.1200/jco.2006.05.6986openalex-snapshot
High-Risk Neuroblastoma Treated With Tandem Autologous Peripheral-Blood Stem Cell–Supported Transplantation: Long-Term Survival Update
inferredcites →https://doi.org/10.1371/journal.pmed.0020313openalex-snapshot
Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
inferredcites →https://doi.org/10.1371/journal.pone.0000255openalex-snapshot
Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4834038openalex-extracted
Molecular Subtypes of Amino Acid Metabolism-Related Genes Predicting Prognosis, Tumor Microenvironment Composition, and Therapeutic Response in Neuroblastoma
inferred← citeshttps://doi.org/10.1002/1878-0261.12069openalex-snapshot
Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on‐target ALK inhibitors in neuroblastoma
inferred← citeshttps://doi.org/10.1002/1878-0261.12969openalex-snapshot
Tumour‐derived substrate‐adherent cells promote neuroblastoma survival through secreted trophic factors
inferred← citeshttps://doi.org/10.1002/9780470555293.app03openalex-snapshot
Appendix III: Tumor Associated Mutations in ALK
inferred← citeshttps://doi.org/10.1002/9781118468791.ch35openalex-snapshot
TargetingALKRearrangements
inferred← citeshttps://doi.org/10.1002/9781118681121.ch16openalex-snapshot
The Role of Structural Biology in Kinase Inhibitor Drug Discovery Success
inferred← citeshttps://doi.org/10.1002/9781118795569.ch19openalex-snapshot
Tumors of endocrine glands
inferred← citeshttps://doi.org/10.1002/adma.202103258openalex-snapshot
Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer Therapy
inferred← citeshttps://doi.org/10.1002/ajh.25043openalex-snapshot
Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study
inferred← citeshttps://doi.org/10.1002/cam4.414openalex-snapshot
Detection of tumor ALK status in neuroblastoma patients using peripheral blood
inferred← citeshttps://doi.org/10.1002/cam4.70082openalex-snapshot
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma
inferred← citeshttps://doi.org/10.1002/cbin.12013openalex-snapshot
Correlation between ARID1B gene mutation (p.A460, p.V215G) and prognosis of high‐risk refractory neuroblastoma
inferred← citeshttps://doi.org/10.1002/cncr.26133openalex-snapshot
Perifosine‐induced inhibition of akt attenuates brain‐derived neurotrophic factor/TrkB‐induced chemoresistance in neuroblastoma in vivo
inferred← citeshttps://doi.org/10.1002/cncr.29706openalex-snapshot
Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations
inferred← citeshttps://doi.org/10.1002/cnr2.1687openalex-snapshot
Targeted parallel DNA sequencing detects circulating tumor‐associated variants of the mitochondrial and nuclear genomes in patients with neuroblastoma
inferred← citeshttps://doi.org/10.1002/ctm2.533openalex-snapshot
The oral KIF11 inhibitor 4SC‐205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models
inferred← citeshttps://doi.org/10.1002/ddr.22026openalex-snapshot
Progress of small molecules for targeted protein degradation: PROTACs and other technologies
inferred← citeshttps://doi.org/10.1002/dneu.22056openalex-snapshot
Jelly belly trans‐synaptic signaling to anaplastic lymphoma kinase regulates neurotransmission strength and synapse architecture
inferred← citeshttps://doi.org/10.1002/gcc.20839openalex-snapshot
ALK rearrangement in sickle cell trait‐associated renal medullary carcinoma
inferred← citeshttps://doi.org/10.1002/gcc.22223openalex-snapshot
Intragenic anaplastic lymphoma kinase (ALK) rearrangements: Translocations as a novel mechanism of ALK activation in neuroblastoma tumors
inferred← citeshttps://doi.org/10.1002/gcc.22790openalex-snapshot
Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangements
inferred← citeshttps://doi.org/10.1002/gcc.22826openalex-snapshot
Adult‐onset neuroblastoma: Report of seven cases with molecular genetic characterization
inferred← citeshttps://doi.org/10.1002/hon.2455openalex-snapshot
Partial deletion of the ALK gene in ALK ‐positive anaplastic large cell lymphoma
inferred← citeshttps://doi.org/10.1002/humu.21442openalex-snapshot
Germline gain-of-function mutations of ALK disrupt central nervous system development
inferred← citeshttps://doi.org/10.1002/ijc.24606openalex-snapshot
Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model
inferred← citeshttps://doi.org/10.1002/ijc.25110openalex-snapshot
Antitumorigenic effects of a mutant of the heparin affin regulatory peptide on the U87 MG glioblastoma cell line
inferred← citeshttps://doi.org/10.1002/ijc.26133openalex-snapshot
Isolation of disseminated neuroblastoma cells from bone marrow aspirates for pretreatment risk assessment by array comparative genomic hybridization
inferred← citeshttps://doi.org/10.1002/ijc.27781openalex-snapshot
Mitogen‐activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere‐associated protein E inhibition
inferred← citeshttps://doi.org/10.1002/ijc.27787openalex-snapshot
Next‐generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN‐amplified neuroblastoma
inferred← citeshttps://doi.org/10.1002/ijc.29077openalex-snapshot
Recent insights into the biology of neuroblastoma
inferred← citeshttps://doi.org/10.1002/ijc.33839openalex-snapshot
Neuroblastoma—Telomere maintenance, deregulated signaling transduction and beyond
inferred← citeshttps://doi.org/10.1002/jcb.22094openalex-snapshot
New therapeutic targets for the treatment of high‐risk neuroblastoma
inferred← citeshttps://doi.org/10.1002/mc.21836openalex-snapshot
Assessment of the transforming potential of novel anaplastic lymphoma kinase point mutants
inferred← citeshttps://doi.org/10.1002/mc.22589openalex-snapshot
Genetic variants in the promoter region of the calcium‐sensing receptor gene are associated with its down‐regulation in neuroblastic tumors
inferred← citeshttps://doi.org/10.1002/mc.22591openalex-snapshot
Genome‐wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumor suppressor gene in neuroblastoma
inferred← citeshttps://doi.org/10.1002/med.21750openalex-snapshot
Molecular targeting therapies for neuroblastoma: Progress and challenges
inferred← citeshttps://doi.org/10.1002/path.4950openalex-snapshot
Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
inferred← citeshttps://doi.org/10.1002/pbc.22579openalex-snapshot
Steps forward in neuroblastoma genetic epidemiology
inferred← citeshttps://doi.org/10.1002/pbc.24116openalex-snapshot
New aspects of neuroblastoma treatment: ASPHO 2011 symposium review
inferred← citeshttps://doi.org/10.1002/pbc.25552openalex-snapshot
Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma Group
inferred← citeshttps://doi.org/10.1002/pbc.28191openalex-snapshot
The ASPHO 2020 distinguished career award goes to Dr Garrett M. Brodeur
inferred← citeshttps://doi.org/10.1002/pbc.28267openalex-snapshot
Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma
inferred← citeshttps://doi.org/10.1002/pbc.31176openalex-snapshot
Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma
inferred← citeshttps://doi.org/10.1002/pbc.31845openalex-snapshot
Pulmonary Toxicity Associated With Concurrent Lorlatinib and Anti‐GD2 Monoclonal Antibody Therapy in Patients With Neuroblastoma
inferred← citeshttps://doi.org/10.1002/smll.201906426openalex-snapshot
Combined Replenishment of miR‐34a and let‐7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models
inferred← citeshttps://doi.org/10.1007/174_2013_828openalex-snapshot
Radioimmunotherapy of Neuroblastoma
inferred← citeshttps://doi.org/10.1007/978-1-4419-6033-7_4openalex-snapshot
Genetics and Genomics of Neuroblastoma
inferred← citeshttps://doi.org/10.1007/978-1-4614-3197-8_10openalex-snapshot
Molecular Targeted Therapy of Lung Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4939-2053-2_10openalex-snapshot
Targeting Receptor Tyrosine Kinases in Cancer
inferred← citeshttps://doi.org/10.1007/978-1-62703-116-5_8openalex-snapshot
Soft Tissue “Small Round Blue Cell Tumors” of Childhood
inferred← citeshttps://doi.org/10.1007/978-3-030-18396-7_3openalex-snapshot
Neuroblastoma Pathogenesis
inferred← citeshttps://doi.org/10.1007/978-3-031-51292-6_11openalex-snapshot
Therapeutically Actionable Genetic Aberrations
inferred← citeshttps://doi.org/10.1007/978-3-031-51292-6_4openalex-snapshot
Somatic Genomic Alterations in Neuroblastoma
inferred← citeshttps://doi.org/10.1007/978-3-031-51292-6_6openalex-snapshot
The Genetic Basis of the Divergent Clinical Courses in Neuroblastoma
inferred← citeshttps://doi.org/10.1007/978-3-032-16833-7_16openalex-snapshot
Golgi Retention and Oncogenic Signaling of KIT Tyrosine Kinase in Gastrointestinal Stromal Tumor
inferred← citeshttps://doi.org/10.1007/978-3-319-30654-4_20openalex-snapshot
Neuroblastoma and Its Zebrafish Model
inferred← citeshttps://doi.org/10.1007/978-3-319-46038-3_5openalex-snapshot
Molecular Genetics of Neuroblastoma
inferred← citeshttps://doi.org/10.1007/978-3-319-89626-7_8openalex-snapshot
Neuroblastoma and Neuroblastic Tumors
inferred← citeshttps://doi.org/10.1007/978-3-642-02202-9_350openalex-snapshot
Neuroblastoma and Other Sympathetic Nervous System Tumors
inferred← citeshttps://doi.org/10.1007/978-4-431-55381-6_8openalex-snapshot
The Involvement of Midkine, a Heparin-Binding Growth Factor, in Cancer Development
inferred← citeshttps://doi.org/10.1007/978-94-007-2418-1_19openalex-snapshot
Advanced Neuroblastoma: Role of ALK Mutations
inferred← citeshttps://doi.org/10.1007/978-94-007-2418-1_21openalex-snapshot
Genomic Profiling of Neuroblastoma Tumors – Prognostic Impact of Genomic Aberrations
inferred← citeshttps://doi.org/10.1007/978-94-007-2418-1_7openalex-snapshot
A Comprehensive Tissue Microarray-Based FISH Screen of ALK Gene in Neuroblastomas
inferred← citeshttps://doi.org/10.1007/978-94-007-4234-5_2openalex-snapshot
The Role of Midkine in Neural Development and Patterning
inferred← citeshttps://doi.org/10.1007/978-94-007-6591-7_4openalex-snapshot
Role of PI3K Inhibitors in Sensitizing Neuroblastoma Cells to Apoptosis
inferred← citeshttps://doi.org/10.1007/s00018-015-2117-6openalex-snapshot
Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs
inferred← citeshttps://doi.org/10.1007/s00109-009-0460-5openalex-snapshot
Anaplastic lymphoma kinase: an oncogene for tumor vaccination
inferred← citeshttps://doi.org/10.1007/s00280-014-2451-7openalex-snapshot
Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells
inferred← citeshttps://doi.org/10.1007/s00280-018-3615-7openalex-snapshot
Targeting ALK in pediatric RMS does not induce antitumor activity in vivo
inferred← citeshttps://doi.org/10.1007/s00383-009-2503-yopenalex-snapshot
Carbon dioxide modifies the morphology and function of mesothelial cells and facilitates transepithelial neuroblastoma cell migration
inferred← citeshttps://doi.org/10.1007/s00428-022-03389-2openalex-snapshot
TIMP3::ALK fusions characterize a distinctive myxoid fibroblastic tumor of the vocal cords: a report of 7 cases
inferred← citeshttps://doi.org/10.1007/s00432-014-1589-3openalex-snapshot
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
inferred← citeshttps://doi.org/10.1007/s00441-017-2702-0openalex-snapshot
Zebrafish as a model to study neuroblastoma development
inferred← citeshttps://doi.org/10.1007/s00441-017-2784-8openalex-snapshot
The ALK receptor in sympathetic neuron development and neuroblastoma
inferred← citeshttps://doi.org/10.1007/s00441-018-2796-zopenalex-snapshot
Origin and initiation mechanisms of neuroblastoma
inferred← citeshttps://doi.org/10.1007/s00441-018-2820-3openalex-snapshot
Genetic susceptibility to neuroblastoma: current knowledge and future directions
inferred← citeshttps://doi.org/10.1007/s00441-018-2821-2openalex-snapshot
Neuroblastoma: clinical and biological approach to risk stratification and treatment
inferred← citeshttps://doi.org/10.1007/s10120-015-0545-5openalex-snapshot
MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer
inferred← citeshttps://doi.org/10.1007/s10147-012-0415-7openalex-snapshot
Molecular and genetic bases of neuroblastoma
inferred← citeshttps://doi.org/10.1007/s10147-012-0417-5openalex-snapshot
Development of treatment strategies for advanced neuroblastoma
inferred← citeshttps://doi.org/10.1007/s10495-009-0325-yopenalex-snapshot
Embryonal neural tumours and cell death
inferred← citeshttps://doi.org/10.1007/s10555-020-09843-4openalex-snapshot
Genetic predisposition and chromosome instability in neuroblastoma
inferred← citeshttps://doi.org/10.1007/s11060-019-03348-zopenalex-snapshot
cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma
inferred← citeshttps://doi.org/10.1007/s11523-012-0227-8openalex-snapshot
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma
inferred← citeshttps://doi.org/10.1007/s11864-021-00898-1openalex-snapshot
Biomarkers in Neuroblastoma: An Insight into Their Potential Diagnostic and Prognostic Utilities
inferred← citeshttps://doi.org/10.1007/s11912-009-0059-6openalex-snapshot
Neuroblastoma: Biology and staging
inferred← citeshttps://doi.org/10.1007/s11912-025-01650-wopenalex-snapshot
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL
inferred← citeshttps://doi.org/10.1007/s12010-019-03156-1openalex-snapshot
Density Functional Theory and Molecular Simulation Studies for Prioritizing Anaplastic Lymphoma Kinase Inhibitors
inferred← citeshttps://doi.org/10.1007/s12035-016-0046-5openalex-snapshot
Exploring Missense Mutations in Tyrosine Kinases Implicated with Neurodegeneration
inferred← citeshttps://doi.org/10.1007/s12035-024-04680-wopenalex-snapshot
Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research
inferred← citeshttps://doi.org/10.1007/s12094-011-0732-8openalex-snapshot
Treatment for ALK-mutated non-small-cell lung cancer: a new miracle in the research race
inferred← citeshttps://doi.org/10.1007/s12519-022-00517-5openalex-snapshot
ALK expression, prognostic significance, and its association with MYCN expression in MYCN non-amplified neuroblastoma
inferred← citeshttps://doi.org/10.1007/s13237-026-00703-0openalex-snapshot
MYCN amplification in neuroblastoma: established paradigms, prognostic consensus, and emerging biological paradoxes
inferred← citeshttps://doi.org/10.1007/s13277-013-1422-7openalex-snapshot
The growth inhibitory effect of 17-DMAG on ALK and MYCN double-positive neuroblastoma cell line
inferred← citeshttps://doi.org/10.1007/s13402-011-0048-2openalex-snapshot
Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels
inferred← citeshttps://doi.org/10.1007/s13402-022-00702-8openalex-snapshot
Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models
inferred← citeshttps://doi.org/10.1007/s40272-013-0027-3openalex-snapshot
Potential Therapies for Anaplastic Lymphoma Kinase-Driven Tumors in Children: Progress to Date
inferred← citeshttps://doi.org/10.1007/s40291-013-0019-6openalex-snapshot
New Insights into the Genetics of Neuroblastoma
inferred← citeshttps://doi.org/10.1007/s40487-020-00113-5openalex-snapshot
Identification of Novel Small-Molecule Kinase Modulators for the Treatment of Neuroblastoma
inferred← citeshttps://doi.org/10.1007/s42399-020-00685-3openalex-snapshot
A Giant Lung Tumor Disappeared After Crizotinib Treatment in an Elder Heavy Smoker: a Case Report
inferred← citeshttps://doi.org/10.1016/b978-0-12-380916-2.00004-8openalex-snapshot
The Connections Between Neural Crest Development and Neuroblastoma
inferred← citeshttps://doi.org/10.1016/b978-0-12-384892-5.00005-0openalex-snapshot
Studying Peripheral Sympathetic Nervous System Development and Neuroblastoma in Zebrafish
inferred← citeshttps://doi.org/10.1016/b978-0-12-396521-9.00002-4openalex-snapshot
Pharmacogenomics and Personalized Medicines in Cancer Treatment
inferred← citeshttps://doi.org/10.1016/b978-0-12-812005-7.00014-xopenalex-snapshot
Novel Therapeutic Targets in Neuroblastoma
inferred← citeshttps://doi.org/10.1016/b978-0-12-821774-0.00003-6openalex-snapshot
Drug combinations: A strategy to enhance anti-tumor activity and overcome drug resistance to ALK inhibitors in neuroblastoma
inferred← citeshttps://doi.org/10.1016/b978-0-12-821774-0.00005-xopenalex-snapshot
Resistance mechanisms to ALK TKIs in tumors other than lung cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-821774-0.00010-3openalex-snapshot
The ALK receptor tyrosine kinase journey: From physiological roles to pathological disruptions
inferred← citeshttps://doi.org/10.1016/b978-0-323-66181-2.00011-1openalex-snapshot
Promising Chimeric Antigen Receptors for Non-B-Cell Hematological Malignancies, Pediatric Solid Tumors, and Carcinomas
inferred← citeshttps://doi.org/10.1016/b978-0-323-85654-6.00028-9openalex-snapshot
Tumors of the nervous system
inferred← citeshttps://doi.org/10.1016/b978-0-443-15717-2.00072-xopenalex-snapshot
Stem Cell Therapy for High-Risk Neuroblastoma: Stem Cell Transplantation and Targeting Cancer Stem Cells
inferred← citeshttps://doi.org/10.1016/b978-1-4160-3431-5.00005-4openalex-snapshot
Cytogenetic and Molecular Pathology of Pediatric Cancer
inferred← citeshttps://doi.org/10.1016/b978-1-4557-5414-4.00044-9openalex-snapshot
10.1016/b978-1-4557-5414-4.00044-9
inferred← citeshttps://doi.org/10.1016/b978-1-4557-5414-4.00045-0openalex-snapshot
10.1016/b978-1-4557-5414-4.00045-0
inferred← citeshttps://doi.org/10.1016/b978-1-4557-5414-4.00054-1openalex-snapshot
10.1016/b978-1-4557-5414-4.00054-1
inferred← citeshttps://doi.org/10.1016/b978-84-8086-959-1.00492-2openalex-snapshot
10.1016/b978-84-8086-959-1.00492-2
inferred← citeshttps://doi.org/10.1016/bs.mcb.2015.12.003openalex-snapshot
Studying the peripheral sympathetic nervous system and neuroblastoma in zebrafish
inferred← citeshttps://doi.org/10.1016/j.actbio.2015.04.003openalex-snapshot
Focal therapy of neuroblastoma using silk films to deliver kinase and chemotherapeutic agents in vivo
inferred← citeshttps://doi.org/10.1016/j.ajpath.2011.12.003openalex-snapshot
High Anaplastic Lymphoma Kinase Immunohistochemical Staining in Neuroblastoma and Ganglioneuroblastoma Is an Independent Predictor of Poor Outcome
inferred← citeshttps://doi.org/10.1016/j.ajpath.2012.01.008openalex-snapshot
MicroRNA 96 Is a Post-Transcriptional Suppressor of Anaplastic Lymphoma Kinase Expression
inferred← citeshttps://doi.org/10.1016/j.ajpath.2015.10.016openalex-snapshot
Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.ajpath.2021.06.009openalex-snapshot
Anaplastic Lymphoma Kinase Overexpression Is Associated with Aggressive Phenotypic Characteristics of Ovarian High-Grade Serous Carcinoma
inferred← citeshttps://doi.org/10.1016/j.bbagen.2009.02.003openalex-snapshot
Integrative genomic approaches to understanding cancer
inferred← citeshttps://doi.org/10.1016/j.bbcan.2021.188571openalex-snapshot
Data-driven approaches to advance research and clinical care for pediatric cancer
inferred← citeshttps://doi.org/10.1016/j.bbr.2017.01.003openalex-snapshot
Genetic inhibition of Anaplastic Lymphoma Kinase rescues cognitive impairments in Neurofibromatosis 1 mutant mice
inferred← citeshttps://doi.org/10.1016/j.bbr.2017.06.024openalex-snapshot
Pharmacological inhibition of Anaplastic Lymphoma Kinase rescues spatial memory impairments in Neurofibromatosis 1 mutant mice
inferred← citeshttps://doi.org/10.1016/j.bbr.2022.113767openalex-snapshot
Long-term effects of pharmacological inhibition of anaplastic lymphoma kinase in neurofibromatosis 1 mutant mice
inferred← citeshttps://doi.org/10.1016/j.bbrc.2015.01.017openalex-snapshot
Inhibition of Mer and Axl receptor tyrosine kinases leads to increased apoptosis and improved chemosensitivity in human neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.bcp.2014.09.016openalex-snapshot
Exposure of neuroblastoma cell lines to imatinib results in the upregulation of the CDK inhibitor p27KIP1 as a consequence of c-Abl inhibition
inferred← citeshttps://doi.org/10.1016/j.biopha.2013.08.010openalex-snapshot
Ellagic acid induces a dose- and time-dependent depolarization of mitochondria and activation of caspase-9 and -3 in human neuroblastoma cells
inferred← citeshttps://doi.org/10.1016/j.bmc.2009.03.046openalex-snapshot
Design and synthesis of a novel tyrosine kinase inhibitor template
inferred← citeshttps://doi.org/10.1016/j.bmc.2014.01.007openalex-snapshot
Synthesis and biological evaluation of benzo[4,5]imidazo[1,2-c]pyrimidine and benzo[4,5]imidazo[1,2-a]pyrazine derivatives as anaplastic lymphoma kinase inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.10.115openalex-snapshot
Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models
inferred← citeshttps://doi.org/10.1016/j.bmcl.2011.05.103openalex-snapshot
Synthesis of an aryloxy oxo pyrimidinone library that displays ALK-selective inhibition
inferred← citeshttps://doi.org/10.1016/j.bmcl.2013.06.071openalex-snapshot
Discovery of 7-azaindole based anaplastic lymphoma kinase (ALK) inhibitors: Wild type and mutant (L1196M) active compounds with unique binding mode
inferred← citeshttps://doi.org/10.1016/j.bmcl.2015.01.019openalex-snapshot
Piperidine-3,4-diol and piperidine-3-ol derivatives of pyrrolo[2,1-f][1,2,4]triazine as inhibitors of anaplastic lymphoma kinase
inferred← citeshttps://doi.org/10.1016/j.bmcl.2019.01.037openalex-snapshot
Discovery of 3,6-diaryl-1H-pyrazolo[3,4-b]pyridines as potent anaplastic lymphoma kinase (ALK) inhibitors
inferred← citeshttps://doi.org/10.1016/j.brainres.2021.147594openalex-snapshot
Role of the parental NF1 carrier in effects of pharmacological inhibition of anaplastic lymphoma kinase in Neurofibromatosis 1 mutant mice
inferred← citeshttps://doi.org/10.1016/j.cancergen.2011.03.001openalex-snapshot
Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.cancergen.2013.07.001openalex-snapshot
ALK as a paradigm of oncogenic promiscuity: different mechanisms of activation and different fusion partners drive tumors of different lineages
inferred← citeshttps://doi.org/10.1016/j.canlet.2010.05.014openalex-snapshot
All-trans retinoic acid downregulates ALK in neuroblastoma cell lines and induces apoptosis in neuroblastoma cell lines with activated ALK
inferred← citeshttps://doi.org/10.1016/j.canlet.2010.09.001openalex-snapshot
Anaplastic Lymphoma Kinase: Role in specific tumours, and development of small molecule inhibitors for cancer therapy
inferred← citeshttps://doi.org/10.1016/j.canlet.2011.11.013openalex-snapshot
Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors
inferred← citeshttps://doi.org/10.1016/j.canlet.2016.01.018openalex-snapshot
Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model
inferred← citeshttps://doi.org/10.1016/j.canlet.2026.218781openalex-snapshot
A human stem cell model of neuroblastoma identifies four chromosome 17q genes that drive tumor initiation and progression
inferred← citeshttps://doi.org/10.1016/j.ccell.2014.09.014openalex-snapshot
The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation
inferred← citeshttps://doi.org/10.1016/j.ccell.2014.09.019openalex-snapshot
ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.ccell.2023.11.004openalex-snapshot
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells
inferred← citeshttps://doi.org/10.1016/j.ccell.2024.10.003openalex-snapshot
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.ccr.2008.12.008openalex-snapshot
Unholy Matrimony: Aurora A and N-Myc as Malignant Partners in Neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.ccr.2011.04.004openalex-snapshot
CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant
inferred← citeshttps://doi.org/10.1016/j.ccr.2012.02.010openalex-snapshot
Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
inferred← citeshttps://doi.org/10.1016/j.ccr.2012.06.001openalex-snapshot
The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.cdtm.2019.08.006openalex-snapshot
Cyclin‐dependent kinase 7 inhibitor THZ1 in cancer therapy
inferred← citeshttps://doi.org/10.1016/j.cell.2009.04.034openalex-snapshot
Commonality but Diversity in Cancer Gene Fusions
inferred← citeshttps://doi.org/10.1016/j.cell.2011.06.040openalex-snapshot
Anaplastic Lymphoma Kinase Spares Organ Growth during Nutrient Restriction in Drosophila
inferred← citeshttps://doi.org/10.1016/j.cell.2014.10.024openalex-snapshot
CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
inferred← citeshttps://doi.org/10.1016/j.cellsig.2013.02.020openalex-snapshot
Control of ALK (wild type and mutated forms) phosphorylation: Specific role of the phosphatase PTP1B
inferred← citeshttps://doi.org/10.1016/j.celrep.2017.02.065openalex-snapshot
Critical Role for GAB2 in Neuroblastoma Pathogenesis through the Promotion of SHP2/MYCN Cooperation
inferred← citeshttps://doi.org/10.1016/j.celrep.2021.109363openalex-snapshot
Extracellular domain shedding of the ALK receptor mediates neuroblastoma cell migration
inferred← citeshttps://doi.org/10.1016/j.celrep.2022.111000openalex-snapshot
Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.celrep.2024.113927openalex-snapshot
ALK upregulates POSTN and WNT signaling to drive neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.clineuro.2017.10.030openalex-snapshot
WITHDRAWN: Bioinformatic analysis of the roles of CDK2 in neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.cllc.2013.04.006openalex-snapshot
Crizotinib in the Treatment of Non–Small-Cell Lung Cancer
inferred← citeshttps://doi.org/10.1016/j.coph.2015.05.010openalex-snapshot
Anaplastic lymphoma kinase inhibitors
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2012.02.005openalex-snapshot
Anaplastic large cell lymphoma, ALK-positive
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2025.104882openalex-snapshot
Therapeutic potential of lorlatinib in ALK-mutated metastatic paraganglioma: Insights from clinical case report and literature review
inferred← citeshttps://doi.org/10.1016/j.csbj.2022.06.024openalex-snapshot
Gene utility recapitulates chromosomal aberrancies in advanced stage neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.ctrv.2010.02.006openalex-snapshot
Neuroblastoma: Therapeutic strategies for a clinical enigma
inferred← citeshttps://doi.org/10.1016/j.ejca.2010.04.006openalex-snapshot
The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene
inferred← citeshttps://doi.org/10.1016/j.ejca.2012.02.001openalex-snapshot
ALK translocation and crizotinib in non-small cell lung cancer: An evolving paradigm in oncology drug development
inferred← citeshttps://doi.org/10.1016/j.ejca.2021.08.022openalex-snapshot
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies
inferred← citeshttps://doi.org/10.1016/j.ejcped.2024.100177openalex-snapshot
DNA repair and replicative stress addiction in neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.03.071openalex-snapshot
Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK)
inferred← citeshttps://doi.org/10.1016/j.ejmech.2022.114626openalex-snapshot
Design, synthesis and antitumor evaluation of ATP dual-mimic 2,4-diarylaminopyrimidine and aminoindazole conjugates as potent anaplastic lymphoma kinase inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejphar.2022.175030openalex-snapshot
Neuroblastoma: Essential genetic pathways and current therapeutic options
inferred← citeshttps://doi.org/10.1016/j.fmre.2022.08.005openalex-snapshot
Advances in liquid biopsy in neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.gdata.2015.07.016openalex-snapshot
DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights
inferred← citeshttps://doi.org/10.1016/j.gde.2017.03.008openalex-snapshot
Genetic susceptibility to neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.ghir.2025.101638openalex-snapshot
Picropodophyllotoxin alters EMT in neuroblastoma via inhibition of surface receptors IGF1R and ALK
inferred← citeshttps://doi.org/10.1016/j.hoc.2009.11.011openalex-snapshot
Neuroblastoma: Biology, Prognosis, and Treatment
inferred← citeshttps://doi.org/10.1016/j.humpath.2009.05.002openalex-snapshot
Aberrant copy numbers of ALK gene is a frequent genetic alteration in neuroblastomas
inferred← citeshttps://doi.org/10.1016/j.humpath.2010.07.024openalex-snapshot
Anaplastic lymphoma kinase expression in neuroblastomas and its relationship with genetic, prognostic, and predictive factors
inferred← citeshttps://doi.org/10.1016/j.isci.2019.06.001openalex-snapshot
Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma
inferred← citeshttps://doi.org/10.1016/j.isci.2023.108096openalex-snapshot
Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma
inferred← citeshttps://doi.org/10.1016/j.isci.2025.113887openalex-snapshot
Resource: A compendium of HLA types and expression in pediatric cancer models
inferred← citeshttps://doi.org/10.1016/j.jbc.2022.102226openalex-snapshot
Identification of cell type–specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors
showing the first 200 of 851 · page through all 851
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.